{"id":"W2905496875","doi":"10.1016/j.biotechadv.2018.12.002","title":"Standardizing CAR-T therapy: Getting it scaled up","year":2018,"lang":"en","type":"review","venue":"Biotechnology Advances","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":47,"is_retracted":false,"has_abstract":false,"ca_institutions":"","funders":"Health Canada; Jiangnan University; National Natural Science Foundation of China; Six Talent Peaks Project in Jiangsu Province; Natural Science Foundation of Jiangsu Province; Government of Jiangsu Province; University of Pennsylvania; Gilead Sciences","keywords":"CAR T-cell therapy; Production (economics); Cancer therapy; Monoclonal antibody; Key (lock); Computer science; Medicine; Business; Cancer; Immunotherapy; Antibody; Immunology; Internal medicine; Chimeric antigen receptor; Economics","routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0008558003,0.0007024482,0.002749561,0.0008186138,0.0002607725,0.00004049738,0.0007276217,0.001969564,0.001539242],"category_scores_gemma":[0.0005495807,0.0005251736,0.0007179735,0.001019345,0.001130918,0.0001114768,0.0002872514,0.001819432,0.0002966069],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004209782,"about_ca_system_score_gemma":0.0005571383,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000009488281,"about_ca_topic_score_gemma":0.00001379244,"domain_scores_codex":[0.9963576,0.0001973396,0.0008371684,0.001100213,0.0005771101,0.0009305509],"domain_scores_gemma":[0.9974295,0.0004007853,0.0004525379,0.001372404,0.000194951,0.000149759],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00009832527,0.00003868981,0.000006755189,0.004151343,0.0004279798,0.00008634969,0.00003148431,2.701915e-8,0.0003938702,0.00008281552,0.001386455,0.9932959],"study_design_scores_gemma":[0.0008457293,0.0005385794,3.151063e-7,0.008762497,0.0002662442,0.0004162041,0.00009910167,0.000001467856,0.002305063,0.0001135489,0.9861814,0.0004698223],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.00003748665,0.9919172,0.0001556395,0.0009165134,0.0008533957,0.001762569,0.00004994201,0.000635829,0.003671421],"genre_scores_gemma":[0.000006660242,0.9898939,0.001636002,0.0001640113,0.0008490614,0.0002113689,0.00006370694,0.0001638098,0.007011457],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9928261,"threshold_uncertainty_score":0.99972,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.0709283191270123,"score_gpt":0.4124309006885732,"score_spread":0.3415025815615609,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}